Improving Outcomes in Advanced RCC: Translating Evidence to Clinical Practice

A discussion on recent advances in the treatment of advanced renal cell carcinoma and their impact on clinical practice, illustrated by real-world patient profiles.

EP. 21: Using Cabozantinib + Nivolumab to Treat Advanced Renal Cell Carcinoma

May 4th 2022

A discussion on the use of cabozantinib-nivolumab for the treatment of advanced renal cell carcinoma.

EP. 22: The Future of Advanced Renal Cell Carcinoma Management

May 4th 2022

Drs Sumeet Bhatia and Eric Jonasch highlight unmet needs in advanced renal cell carcinoma and share clinical pearls.

EP. 23: Patient Profile Presentation: A 56-Year-Old Man with Metastatic Clear Cell RCC

May 25th 2022

Robert Alter, MD, presents the patient profile of a 56-year-old man with metastatic clear cell renal cell carcinoma presenting with chromaturia.

EP. 24: Front-Line Lenvatinib + Pembrolizumab Combination Regimens for Advanced RCC: Selecting Patients and Dose

May 25th 2022

A review of the first-line I/O-TKI combination regimens available for advanced RCC and selecting the right patients and dose for treatment with lenvatinib and pembrolizumab.

EP. 25: Toxicities with IO-TKI Combination Regimens for Advanced RCC and Their Management

June 2nd 2022

Elan Diamond, MD, explains toxicities commonly seen with I/O–TKI combination regimens, how to manage them, and how to discuss toxicities with patients with advanced renal cell carcinoma.

EP. 26: Sequencing Therapies for Advanced RCC

June 2nd 2022

Experts discuss how they sequence I/O–TKI treatments for advanced renal cell carcinoma.

EP. 27: Patient Profile Presentation: A 70-Year-Old Man with Stage 4 Clear Cell RCC

June 8th 2022

Dr Elan Diamond presents the patient profile of a 70-year-old man with stage IV clear cell renal cell carcinoma.

EP. 28: Nivolumab + Ipilimumab Combination Regimen for Advanced RCC

June 8th 2022

Oncologists review the IO/IO combination regimens available for treatment of advanced RCC and discuss patient selection for treatment with nivolumab and ipilimumab.

EP. 29: Advanced RCC Patient Referrals from Community Oncologists

June 16th 2022

Elan Diamond, MD, describes when and how often community oncologists refer patients with suspected advanced renal cell carcinoma to his practice.

EP. 30: Patient Profile Presentation: A 56-Year-Old Man with Clear Cell RCC

June 16th 2022

Robert Alter, MD, presents the patient profile of a 56-year-old man with clear cell renal cell carcinoma presenting with hip and leg pain.